Naiga Dohnji, NP
Nurse Practitioner · Santa Fe
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Forefront Telecare Inc · St Vincent Hospital
Looking this up.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Naiga Dohnji’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Medicaid work
$4,452 in 2019
Medicaid paid $4,452 for 148 billed services this clinician did in 2019, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 75 | $2,420 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 73 | $2,032 |
| 2019 | 148 | 2 | 46 | $4,452 |
| 2018 | 711 | 2 | 71 | $7,023 |
See the largest Medicaid services in earlier years
2018
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 443 | $4,446 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 268 | $2,578 |
Drugs they prescribed that Part D paid
$8,327
Pharmacies billed $8,327 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 165) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
160 generic and fewer than 11 brand-name prescriptions · $8,327 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 16 | $262 | $16 |
| Buspirone | 14 | $250 | $18 |
| Lamotrigine | 11 | $153 | $14 |
| Mirtazapine | 15 | $110 | $7 |
| Quetiapine | 14 | $91 | $7 |
Year by year
| 2024 | 165 | 23 | 0% (0) | None | $8,327 |
| 2023 | 155 | 28 | 0% (0) | None | $7,178 |
| 2022 | 183 | 31 | 0% (0) | None | $10,052 |
| 2021 | 593 | 60 | 0% (0) | 2% | $47,685 |
| 2020 | 561 | 63 | 0% (0) | 6% | $78,221 |
| 2019 | 509 | 45 | 0% (0) | None | $20,173 |
| 2018 | 335 | 37 | 0% (0) | 4% | $17,069 |
| 2017 | 16 | None | 0% (0) | 0% | $183 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Clozapine | 14 | $1,006 | $72 |
| Quetiapine | 12 | $533 | $44 |
| Duloxetine | 13 | $133 | $10 |
| Trazodone | 18 | $85 | $5 |
2022: 8 drugs
| Clozapine | 14 | $956 | $68 |
| Gabapentin | 13 | $214 | $16 |
| Quetiapine | 12 | $191 | $16 |
| Hydroxyzine | 14 | $184 | $13 |
| Fluoxetine | 12 | $140 | $12 |
| Trazodone | 15 | $136 | $9 |
| Clonazepam | 12 | $119 | $10 |
| Alprazolam | 13 | $41 | $3 |
2021: 20 drugs
| Buprenorphine-Naloxone | 15 | $2,283 | $152 |
| Oxcarbazepine | 19 | $1,582 | $83 |
| Buspirone | 39 | $1,377 | $35 |
| Quetiapine | 36 | $1,121 | $31 |
| Bupropion Xl | 21 | $851 | $41 |
| Prazosin | 15 | $781 | $52 |
| Divalproex | 12 | $758 | $63 |
| Gabapentin | 21 | $536 | $26 |
| Sertraline | 20 | $523 | $26 |
| Venlafaxine Hcl Er | 25 | $480 | $19 |
| Trazodone | 41 | $479 | $12 |
| Duloxetine | 15 | $352 | $23 |
| Clonazepam | 52 | $325 | $6 |
| Mirtazapine | 18 | $217 | $12 |
| Escitalopram | 15 | $208 | $14 |
| Hydroxyzine | 14 | $193 | $14 |
| Alprazolam | 28 | $191 | $7 |
| Fluoxetine | 16 | $165 | $10 |
| Lorazepam | 14 | $104 | $7 |
| Zolpidem | 27 | $85 | $3 |
2020: 16 drugs
| Rexulti | 22 | $35,563 | $1,617 |
| Buspirone | 66 | $1,477 | $22 |
| Sertraline | 48 | $762 | $16 |
| Quetiapine | 43 | $710 | $17 |
| Hydroxyzine | 19 | $596 | $31 |
| Aripiprazole | 12 | $562 | $47 |
| Trazodone | 41 | $531 | $13 |
| Bupropion Xl | 11 | $423 | $38 |
| Gabapentin | 22 | $419 | $19 |
| Olanzapine | 13 | $366 | $28 |
| Clonazepam | 42 | $348 | $8 |
| Venlafaxine Hcl Er | 12 | $275 | $23 |
| Fluoxetine | 20 | $231 | $12 |
| Alprazolam | 31 | $151 | $5 |
| Escitalopram | 12 | $124 | $10 |
| Zolpidem | 29 | $94 | $3 |
2019: 13 drugs
| Aripiprazole | 17 | $2,525 | $149 |
| Buspirone | 58 | $710 | $12 |
| Trazodone | 36 | $601 | $17 |
| Quetiapine | 27 | $522 | $19 |
| Gabapentin | 28 | $458 | $16 |
| Venlafaxine Hcl Er | 18 | $371 | $21 |
| Bupropion Xl | 15 | $370 | $25 |
| Olanzapine | 16 | $346 | $22 |
| Sertraline | 36 | $304 | $8 |
| Clonazepam | 38 | $223 | $6 |
| Zolpidem | 22 | $183 | $8 |
| Fluoxetine | 27 | $125 | $5 |
| Alprazolam | 23 | $117 | $5 |
2018: 12 drugs
| Aripiprazole | 14 | $4,323 | $309 |
| Quetiapine | 22 | $378 | $17 |
| Gabapentin | 19 | $358 | $19 |
| Duloxetine | 14 | $275 | $20 |
| Trazodone | 21 | $269 | $13 |
| Bupropion Hcl Sr | 12 | $165 | $14 |
| Olanzapine | 15 | $165 | $11 |
| Buspirone | 31 | $162 | $5 |
| Sertraline | 12 | $129 | $11 |
| Clonazepam | 34 | $126 | $4 |
| Zolpidem | 19 | $105 | $6 |
| Fluoxetine | 13 | $68 | $5 |
Money from drug and device companies
$1,211 in 2024
| 2024 | 9 | 36 | None | $1,211 |
| 2023 | 12 | 30 | None | $632 |
| 2022 | 1 | 1 | None | $13 |
| 2021 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Supernus Pharmaceuticals | Qelbree | $450 | 5 payments
|
| Abbvie | Vraylar | $326 | 11 payments
|
| Corium | Azstarys | $126 | 5 payments
|
| Lundbeck | Rexulti | $101 | 5 payments
|
| Janssen Pharmaceuticals | Spravato | $71 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $67 | 3 payments
|
See all 36 published payments
| Abbvie | Meals · 2024-07-02 | Vraylar | $18 |
| Supernus Pharmaceuticals | Meals · 2024-07-02 | Qelbree | $17 |
| Lundbeck | Meals · 2024-06-13 | Rexulti | $20 |
| Abbvie | Meals · 2024-06-04 | Vraylar | $21 |
| Supernus Pharmaceuticals | Meals · 2024-06-03 | Qelbree | $17 |
| Teva Pharmaceuticals USA | Meals · 2024-05-29 | Austedo Xr | $35 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2024-05-23 | Caplyta | $21 |
| Corium | Meals · 2024-05-21 | Azstarys | $35 |
| Abbvie | Meals · 2024-05-16 | Vraylar | $21 |
| Lundbeck | Meals · 2024-05-15 | Rexulti | $22 |
| Abbvie | Meals · 2024-05-07 | Vraylar | $19 |
| Abbvie | Meals · 2024-05-02 | Vraylar | $117 |
| Supernus Pharmaceuticals | Meals · 2024-05-01 | Qelbree | $21 |
| Abbvie | Meals · 2024-04-18 | Vraylar | $19 |
| Lundbeck | Meals · 2024-04-17 | Rexulti | $18 |
| Abbvie | Meals · 2024-04-09 | Vraylar | $19 |
| Janssen Pharmaceuticals | Meals · 2024-04-08 | Spravato | $18 |
| Supernus Pharmaceuticals | Meals · 2024-04-03 | Qelbree | $19 |
| Janssen Pharmaceuticals | Meals · 2024-03-22 | Spravato | $17 |
| Corium | Meals · 2024-03-19 | Azstarys | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2024-03-14 | Caplyta | $24 |
| Abbvie | Meals · 2024-03-12 | Vraylar | $18 |
| Corium | Meals · 2024-02-22 | Azstarys | $28 |
| Abbvie | Meals · 2024-02-20 | Vraylar | $29 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2024-02-16 | Caplyta | $22 |
| Lundbeck | Meals · 2024-02-14 | Rexulti | $20 |
| Idorsia Pharmaceuticals US | Meals · 2024-02-08 | Quviviq | $20 |
| Janssen Pharmaceuticals | Meals · 2024-02-06 | Spravato | $16 |
| Corium | Meals · 2024-02-02 | Azstarys | $19 |
| Lundbeck | Meals · 2024-01-25 | Rexulti | $21 |
| Abbvie | Meals · 2024-01-23 | Vraylar | $29 |
| Supernus Pharmaceuticals | Meals · 2024-01-19 | Qelbree | $376 |
| Corium | Meals · 2024-01-11 | Azstarys | $21 |
| Janssen Pharmaceuticals | Meals · 2024-01-10 | Spravato | $21 |
| Abbvie | Meals · 2024-01-05 | Vraylar | $17 |
| Tris Pharma | Meals · 2024-01-04 | Dyanavel Xr | $15 |
See earlier years (2023, 2022, 2021)
2023: $632
| Abbvie | Vraylar | $169 | 7 payments
|
| Iti | Caplyta | $89 | 4 payments
|
| Lundbeck | Rexulti | $83 | 4 payments
|
| Janssen Pharmaceuticals | Spravato | $76 | 4 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $73 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $35 | 1 payment
|
| Corium | Azstarys | $26 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $19 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $17 | 1 payment
|
| Almatica Pharma | Loreev Xr | $16 | 1 payment
|
| OWP Pharmaceuticals | Subvenite | $14 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $14 | 1 payment
|
2022: $13
| Abbvie | Vraylar | $13 | 1 payment
|
2021: $22
| Otsuka America Pharmaceutical | Abilify Mycite | $22 | 1 payment
|
Professional record
- NPI
- 1912337205
- Licence
- TX 2158, TX AP122741
- Group
- Forefront Telecare Inc · St Vincent Hospital
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 2521 Stonybrook Dr, Prosper, TX, 75078
- NPI first listed
- 2013-11-22
- NPI last updated
- 2026-09-03
- NPI record certified
- 2026-09-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4314 Yoakum Blvd, Houston, TX, 77006 · 7300 Eldorado Pkwy Ste 225, Mckinney, TX, 75070